The rising toll of uterine/endometrial cancer as reported by The Wall Street Journal’s Brianna Abbott makes it clear it’s time for action. Uterine cancer is the only cancer for which survival has fallen in the past 4 decades and will kill ~13,250 women in the U.S. this year. Strong correlation to

No doubt, it’s an incredibly hard morning over at Amylyx. But Joshua Cohen and Justin Klee you guys are awesome and an inspiration to anyone trying to do something HARD. To build a biologically differentiated biotech company in your metaphorical garage and bring it to

Had a nice chat with Judy Khan Shaw on @faethtx leveraging metabolism to treat cancer and clinical trial successes in relapsed refractory endometrial cancer patients, highlighting the potential of metabolism-based treatments in cancer therapy. #NYSEFloorTalk youtu.be/6MwdnOFtiKE?si…

Great interview with Siddhartha Mukherjee on the future of cancer treatment and the role of AI. Lots of discussion of @FaethTherapeutics as we push boundaries and the field of cancer metabolism together! 🧬🚀 #CancerResearch #AI endpts.com/the-endpoints-…

Great job Andrew Dunn - fun read. Was wonderful catching up with you in NYC a couple weeks ago!

Most people using ML in biotech focus on the predictable - chemistry and physics. But biology is the key to unlocking new breakthroughs for patients. I had the opportunity to pen my thoughts in this column with Drug Discovery & Development . Give it a read and lmk what you think.

For decades, we bet on chemistry—hit the target, block the pathway. But disease isn’t just chemistry. It’s biology: metabolism, immunity, networks in motion. ML is finally decoding the system. The next great medicines will come from new modalities that integrate that

Just look at those LIMBS inside the Tottenham Hotspur Stadium

Absolute carnage at the Tottenham Hotspur stadium 🤣🤣🤣

congratulations Tottenham Hotspur 🤍

😎

Honestly the lack of awareness around endometrial cancer is scary. Only cancer indication that is growing in incidence and mortality. We have to do more and proud of the entire team Faeth Therapeutics for dedicating themselves to this work!

This is so weak. Why write in the “we” - this was clearly a decision by Daniel Levy.

Some got more air than others, and it took me way too long to get a picture that works but glad to be working on uterine cancer. It’s an important disease that deserves more attention.

We're having a go. Finally

Congratulations to Celcuity on their positive Phase 3 data. At Faeth Therapeutics we definitely agree that multi-node inhibition of the PI3K pathway is the way forward.

Alright I’m pretty sure at this point that being a fan of Tottenham Hotspur football club is part of some sick, twisted social experiment

Remarkable that US spending on pharmaceuticals is just ~1.6% of GDP. Amazingly good value for money considering the welfare gains. (And especially given the extent to which the US subsidizes the rest of the world.)